The Yellow Fever Vaccine Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The market size of the Yellow Fever Vaccine has been experiencing substantial growth recently. The market increased from $4.54 billion in 2024 to $4.79 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 5.4%.
The market size for the Yellow Fever Vaccine is forecasted to reach $5.84 billion in 2029, growing at a compound annual growth rate (CAGR) of 5.1%.
Download Your Free Sample of the 2025 Yellow Fever Vaccine Market Report and Uncover Key Trends Now!The drivers in the yellow fever vaccine market are:
• The initiation of global immunization campaigns
• Implementation of international health regulations
• Mass vaccination campaigns
• Advances in vaccine production technology
The yellow fever vaccine market covered in this report is segmented –
1) By Product: Powder, Liquid
2) By Treatment Type: Pain Management Drugs, Oral Rehydration
3) By Application: Routine Immunization, Travelers, Other Applications
4) By End-User: Hospitals, Diagnostic Centers, Point Of Care Centers, Other End Users
The trends in the yellow fever vaccine market are:
• Diversification of vaccine formats is an emerging trend in the market.
• The market is shaped by the need for pandemic preparedness.
• Regulatory changes are significantly influencing the future of the market.
• There is an emerging trend towards improving healthcare infrastructure and improving consumer education and awareness.
The major players in the yellow fever vaccine market are:
• Merck and Co Inc.
North America was the largest region in the yellow fever vaccine market in 2023